Index Catalog // MEDSpace

Start Over

Filtering by: Contributor Li, Fang Platform Presentation No thank you

Description/Abstract:	Background BRAF mutations are common in melanoma, with more than 50% harboring activating BRAF mutations. Though BRAF inhibitors are highly efficacious for nearly half of patients with this BRAF-mutant melanoma, many developing secondary...
Date:	August 1-2, 2024

Limit your search